Literature DB >> 26383654

Draft Genome Sequences of Five Clinical Enterococcus cecorum Strains Isolated from Different Poultry Species in Poland.

Beata Dolka1, Rikke Heidemann Olsen2, Ida Cecilie Naundrup Thøfner2, Jens Peter Christensen2.   

Abstract

Here, we report five draft genome sequences of Enterococcus cecorum strains that were isolated from different bird species of affected poultry flocks (commercial broilers [CB], broiler breeders [BB], commercial layers [CL], ducks [D], and geese [G]) in Poland.
Copyright © 2015 Dolka et al.

Entities:  

Year:  2015        PMID: 26383654      PMCID: PMC4574383          DOI: 10.1128/genomeA.01082-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Enterococcus cecorum is known as a member of the commensal intestinal microbiota in healthy humans and animals, but it can act as a pathogen. From 2002 until today, a growing number of E. cecorum-associated disease outbreaks in poultry flocks, especially broilers and broiler breeders, have been reported worldwide. The most predominant lesions are enterococcal spondylitis (ES), osteomyelitis, arthritis, femur head necrosis (FHN), and bacteremia (1–5). Recently, genomic analysis revealed fundamental differences in pathogenic isolates from chickens in the southeastern United States (6). In the present study, E. cecorum strains were cultivated from tissue samples taken from affected poultry. Bacteria were identified as Enterococcus based on their phenotypic properties. Identification to the species level was done using API rapid ID 32 Strep (bioMérieux, France), PCR amplification of the sodA (superoxide dismutase) fragment gene, and sequencing of PCR products (7). BLAST search results showed 99 to 100% sequence identity with the existing GenBank E. cecorum sequences. We found no high-level gentamicin resistance (HLGR) or vancomycin-resistant enterococci (VRE) in enterococcal strains after using the standard disk diffusion method. E. cecorum strain BB-66 exhibited intermediate susceptibility to vancomycin. Here, we present five draft genome sequences of E. cecorum clinical strains from different poultry species in Poland: commercial broilers (CB-32), broiler breeders (BB-66), commercial layers (CL-1), ducks (D-104), geese (G-29). Good-quality genomic DNA was isolated from pure cultures of E. cecorum CB-32, BB-66, CL-1, G-29, and D-104 and submitted for sequencing. Five genomes were sequenced by the Illumina paired-end method (MiSeq) using a paired-end library (TruSeq Nano DNA), with an average read length of 2 × 150 bp. The reads were trimmed for quality and de novo assembled using CLC Genomics Workbench 7.0. The results of the sequencing are summarized in Table 1. The genome sequences were annotated by the Rapid Annotations using Subsystems Technology (RAST) server (8) and by the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) (9).
TABLE 1

Summary of genome sequencing in the present study

E. cecorum isolateReads (Mb)FoldcoverageNo. ofscaffoldsGenomesize (bp)G+C (%)Accession no.
CB-32132.657.8612,293,16436.5LDEB00000000
BB-66162.265.4622,480,26036.2LDED00000000
CL-1143.861.5472,337,81936.3LDEA00000000
G-29171.980.5462,133,36236.9LDEC00000000
D-104149.965.8282,275,37736.3LDDZ00000000
Summary of genome sequencing in the present study The CB-32 genome consists of 2,267 genes (51 tRNAs and 3 rRNAs) and 2,113 expected coding sequences (CDSs). The genome of BB-66 consists of 2,479 genes (47 tRNAs and 3 rRNAs), of which 2,310 are coding sequences (CDSs). For CL-1, we identified 2,315 genomic features consisting of 2,163 coding sequences (predicted), 40 tRNAs, and 6 rRNAs. The D-104 genome consists of 2,269 genes (55 tRNAs and 10 rRNAs) and 2,115 CDSs. For the G-29 genome, we revealed 2,158 genes (46 tRNAs and 5rRNAs), including 1,987 CDSs. To the best of our knowledge, this is the first genome report of clinical E. cecorum strains isolated from different poultry species in Europe. The sequence data presented here will contribute to understanding the pathogenicity of E. cecorum against poultry.

Nucleotide sequence accession numbers.

The five whole-genome shotgun projects have been deposited at DDBJ/EMBL/GenBank under the accession numbers listed in Table 1. The versions described in this paper are the first versions.
  6 in total

1.  Isolation of Enterococcus cecorum from bone lesions in broiler chickens.

Authors:  A M Wood; G MacKenzie; N C McGiliveray; L Brown; L A Devriese; M Baele
Journal:  Vet Rec       Date:  2002-01-05       Impact factor: 2.695

2.  Use of a genus- and species-specific multiplex PCR for identification of enterococci.

Authors:  Charlene R Jackson; Paula J Fedorka-Cray; John B Barrett
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

3.  Association of Enterococcus cecorum with vertebral osteomyelitis and spondylolisthesis in broiler parent chicks.

Authors:  László Makrai; Csaba Nemes; Anna Simon; Eva Ivanics; Zoltán Dudás; László Fodor; Róbert Glávits
Journal:  Acta Vet Hung       Date:  2011-03       Impact factor: 0.955

4.  An outbreak and source investigation of enterococcal spondylitis in broilers caused by Enterococcus cecorum.

Authors:  Kabel M Robbins; M Mitsu Suyemoto; Roberta L Lyman; Michael P Martin; H John Barnes; Luke B Borst
Journal:  Avian Dis       Date:  2012-12       Impact factor: 1.577

5.  Comparative genomic analysis identifies divergent genomic features of pathogenic Enterococcus cecorum including a type IC CRISPR-Cas system, a capsule locus, an epa-like locus, and putative host tissue binding proteins.

Authors:  Luke B Borst; M Mitsu Suyemoto; Elizabeth H Scholl; Fredrick J Fuller; H John Barnes
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

6.  The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST).

Authors:  Ross Overbeek; Robert Olson; Gordon D Pusch; Gary J Olsen; James J Davis; Terry Disz; Robert A Edwards; Svetlana Gerdes; Bruce Parrello; Maulik Shukla; Veronika Vonstein; Alice R Wattam; Fangfang Xia; Rick Stevens
Journal:  Nucleic Acids Res       Date:  2013-11-29       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.